一致Ｂ：2019年年度报告（英文版）.PDF

《一致Ｂ：2019年年度报告（英文版）.PDF》由会员分享，可在线阅读，更多相关《一致Ｂ：2019年年度报告（英文版）.PDF（368页珍藏版）》请在三个皮匠报告上搜索。

1、China National Accord Medicines Corporation Ltd.Annual Report 2019April 20201Section I.Important Notice,Contents and InterpretationBoard of Directors,Supervisory Committee,all directors,supervisors and seniorexecutives of China National Accord Medicines Corporation Ltd.(hereinafterreferred to as the

2、 Company)hereby confirm that there are no any fictitiousstatements,misleading statements,or important omissions carried in this report,and shall take all responsibilities,individual and/or joint,for the reality,accuracy and completion of the whole contents.Lin Zhaoxiong,Principal of the Company,Wei

3、Pingxiao,person in charger ofaccounting works and Wang Ying,person in charge of accounting organ(accounting principal)hereby confirm that the Financial Report of 2019 AnnualReport is authentic,accurate and complete.All directors are attended the Board Meeting for report deliberation.Affected by vari

4、ous risk factors,the companys business operations are facingrisks in terms of changes in industry policies and intensified market competition.The company has made a specific statement on the“Future DevelopmentProspects”of the fourth section“Discussion and Analysis of the Operation”inthis annual repo

5、rt,and all investors should pay attention to it.The profit distribution plan that deliberated and approved by the Board is:based on total stock issued 428,126,983 shares,distributed 6 Yuan(tax included)bonus in cash for every 10-share hold by all shareholders,0 shares bonus issued(tax included)and n

6、o capitalizing of common reserves carried out.2ContentsSection I.Important Notice,Contents and Interpretation.1Section II Company Profile and Main Financial Indexes.4Section III.Summary of Company Business.8Section IV.Discussion and Analysis of Business.11Section V.Important Events.37Section VI.Chan